Department of Family Medicine, University of Colorado, Denver.
J Fam Pract. 2023 Sep;72(7):E23-E25. doi: 10.12788/jfp.0652.
While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.
虽然二甲双胍治疗或生活方式改变可降低糖尿病前期患者的 T2D 风险,但这两种干预措施最终都不能带来生存获益。